Dr Andy Yale
BVMedSci (Hons) BVM BVS (Hons) PGCertVetEd PGDipVCP MVetMed DipECVIM-CA (Oncology) FHEA MRCVS
Lecturer in Veterinary Oncology (CET)
Department: Clinical Science and Services
Campus: Hawkshead
Research Groups: CPCS (Research Programme)
Clinical Groups: Small Animal Oncology
Andy is an RCVS and European Veterinary Specialist in Small Animal Oncology and Lecturer in Veterinary Oncology at the ºÚÁÏÉç, undertaking clinical work in the Queen Mother Hospital for Animals. Roles include seeing small animal oncology patients, supervising and training oncology residents, teaching undergraduate students, and undertaking research.
Andy graduated from The University of Nottingham before enjoying two years in small animal general practice. He subsequently undertook a small animal rotating internship and medical oncology residency at the Royal Veterinary College, also completing a postgraduate diploma and master's degree. He gained his Diploma in Small Animal Oncology and now works as a Lecturer in Veterinary Oncology.
Clinically, Andy has a particular interest in canine mast cell tumours. His research interests focus on novel diagnostic and therapeutic strategies in veterinary cancer patients, particularly those where there is translational relevance.
Andy is a member of the ºÚÁÏÉç's Comparative Physiology and Clinical Science (CPCS) Management Committee, managing the Oncology research group, and is also a member of the ºÚÁÏÉç's clinical research ethical review board (CRERB). He holds a Home Office personal license (PIL) under the Animals (Scientific Procedures) Act. He is Associate Editor of .
Andy contributes to the wider veterinary profession by providing oncology CPD, and has spoken at national and international conferences.
Peer reviewed research publications
1. Yale A, Crawford A, Gramer I, Guillen A, Desmas I, Holmes E. Large granular lymphocyte lymphoma in 65 dogs (2005 - 2023). Vet Comp Oncol. 2023.
2. Marks T, Rossanese M, Yale A, Stewart S, Smallwood K, Guillen A. Prognostic factors and outcome in cats with thymic epithelial tumours: 64 cases (1999 - 2021). J Small Anim Pract. 2023.
3. McNally A, Rossanese M, Suárez-Bonnet A, Hardas A, Yale A. Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide. J Vet Intern Med. 2023; 1- 5.
4. Treggiari E, Pellin M, Romanelli G, Maresca G, Gramer I, Yale A, Pecceu E, Pegnanelli M, Borrego J, Purzycka K, Berlato D. Tonsillar carcinoma in dogs: Treatment outcome and potential prognostic factors in 123 cases. J Vet Intern Med. 2023;1- 11.
5. Yale A, Priestnall S, Pittaway R, Taylor A. Thymic epithelial tumours in 51 dogs: Histopathologic and clinicopathologic findings. Vet Comp Oncol. 2021;20(1):50-58.
6. Yale A, Szladovits B, Stell A, Fitzgerald S, Priestnall S, Suarez-Bonnet A. High-Grade Cutaneous Mast Cell Tumour with Widespread Intrathoracic Metastasis and Neoplastic Pericardial Effusion in a Dog. J Comp Pathol. 2020;180:29-34.
Andy is involved with the supervision and training of oncology residents, in addition to teaching undergraduate BVetMed students throughout their 3rd, 4th and 5th years of study. He is rotation leader for the 5th year veterinary students' oncology rotation. Andy has completed a postgraduate certificate in veterinary education and is a fellow of the Higher Education Academy.
Associate Editor of .
Peer reviewer for Veterinary and Comparative Oncology, Veterinary Oncology, Topics in Companion Animal Medicine, and Vet Record Case Reports.
Member of assessment panel for RCVS Advanced Practitioner Status.
Trustee of Zeus and PJ Foundation.
-
A Multi-disciplinary Approach to Investigating Canine Diffuse Large B cell Lymphoma
We propose to better define genetic subtypes of canine lymphoma and characterising response to treatment of the different subtypes through a combination of more accurate phenotyping of lymphomas by integrating a) advanced image analysis b) genome sequencing, and c) total RNA sequencing (including micro-RNA sequencing).